Núñez Francisco Freinet, Siqueiros-Marquez Lourdes, Adán-Castro Elva, Zamora Magdalena, Robles Juan Pablo, Ruíz-Herrera Xarubet, Bertsch Thomas, Triebel Jakob, Martínez de la Escalera Gonzalo, Clapp Carmen
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), 76230 Querétaro, México.
Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital and Paracelsus Medical University, 90419 Nuremberg, Germany.
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf023.
Vasoinhibin is a fragment of the hormone prolactin (PRL) that inhibits angiogenesis, vasopermeability, and vasodilation. Cathepsin D (CTSD) cleaves the N-terminal of PRL to generate vasoinhibin in the retina of neonate mice as revealed by the CTSD inhibitor, pepstatin A. However, pepstatin A also inhibits renin. Because renin is expressed in the retina and the renin-angiotensin system gives rise to peptides with positive and negative effects on blood vessel growth and function, we investigated whether renin cleaves PRL to vasoinhibin in the newborn mouse retina and in the circulation. Newborn mouse retinal extracts from wild-type and CTSD-null newborn mice cleaved PRL to a 14 kDa vasoinhibin and such cleavage was prevented by heat-inactivation, pepstatin A, and the selective renin inhibitor VTP-27999 suggesting the contribution of renin. In agreement, recombinant renin cleaved different species PRLs to the expected 14-kDa vasoinhibin, a mass consistent with a consensus renin cleavage site located at Leu124-Leu125 in rat and mouse PRLs and at Leu126-Leu127 in human, bovine, and ovine PRLs. Dehydration followed by rehydration (D/R) in rats increased the levels of renin and PRL in plasma. Further increase in PRL circulating levels by the dopamine D2 receptor blocker, sulpiride, enabled detection of 14 kDa vasoinhibin in D/R rats. Moreover, the incubation of PRL with plasma from D/R rats generated a 14-kDa vasoinhibin that was prevented by VTP-27999. These findings add renin to the list of PRL-cleaving proteases and introduce vasoinhibin as a putative renin-angiotensin system-mediated mechanism for regulating blood vessel growth and function.
血管抑制素是催乳素(PRL)的一个片段,可抑制血管生成、血管通透性和血管舒张。组织蛋白酶D(CTSD)可切割PRL的N端,在新生小鼠视网膜中生成血管抑制素,CTSD抑制剂胃蛋白酶抑制剂A已证实这一点。然而,胃蛋白酶抑制剂A也会抑制肾素。由于肾素在视网膜中表达,且肾素-血管紧张素系统会产生对血管生长和功能有正负两种作用的肽,因此我们研究了肾素是否会在新生小鼠视网膜和循环系统中将PRL切割为血管抑制素。野生型和CTSD基因敲除新生小鼠的新生小鼠视网膜提取物可将PRL切割为14 kDa的血管抑制素,热灭活、胃蛋白酶抑制剂A和选择性肾素抑制剂VTP-27999可阻止这种切割,提示肾素的作用。与此一致的是,重组肾素可将不同物种的PRL切割为预期的14 kDa血管抑制素,该分子量与大鼠和小鼠PRL中位于Leu124-Leu125、人、牛和羊PRL中位于Leu126-Leu127的共有肾素切割位点相符。大鼠脱水后再复水(D/R)会增加血浆中肾素和PRL的水平。多巴胺D2受体阻滞剂舒必利进一步提高PRL循环水平后,可在D/R大鼠中检测到14 kDa的血管抑制素。此外,PRL与D/R大鼠血浆孵育可产生14 kDa的血管抑制素,VTP-27999可阻止其产生。这些发现使肾素成为PRL切割蛋白酶之一,并引入血管抑制素作为肾素-血管紧张素系统介导的调节血管生长和功能的一种假定机制。